AstraZeneca PLC (AZNCF)
156.01
+3.68
(+2.41%)
USD |
OTCM |
May 10, 15:54
AstraZeneca Market Cap: 241.85B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 09, 2024 | 236.15B |
May 08, 2024 | 236.25B |
May 07, 2024 | 227.34B |
May 06, 2024 | 229.79B |
May 03, 2024 | 231.36B |
May 02, 2024 | 237.93B |
May 01, 2024 | 234.12B |
April 30, 2024 | 234.08B |
April 29, 2024 | 226.72B |
April 26, 2024 | 224.94B |
April 25, 2024 | 226.42B |
April 24, 2024 | 209.82B |
April 23, 2024 | 217.50B |
April 22, 2024 | 215.06B |
April 19, 2024 | 211.14B |
April 18, 2024 | 214.30B |
April 17, 2024 | 217.26B |
April 16, 2024 | 209.75B |
April 15, 2024 | 210.74B |
April 12, 2024 | 215.29B |
April 11, 2024 | 211.61B |
April 10, 2024 | 211.22B |
April 09, 2024 | 208.91B |
April 08, 2024 | 211.82B |
April 05, 2024 | 206.52B |
Date | Value |
---|---|
April 04, 2024 | 212.92B |
April 03, 2024 | 204.26B |
April 02, 2024 | 204.10B |
April 01, 2024 | 210.52B |
March 28, 2024 | 212.32B |
March 27, 2024 | 208.82B |
March 26, 2024 | 202.38B |
March 25, 2024 | 206.52B |
March 22, 2024 | 205.20B |
March 21, 2024 | 203.08B |
March 20, 2024 | 203.06B |
March 19, 2024 | 201.43B |
March 18, 2024 | 202.94B |
March 15, 2024 | 203.73B |
March 14, 2024 | 207.92B |
March 13, 2024 | 211.45B |
March 12, 2024 | 206.67B |
March 11, 2024 | 206.76B |
March 08, 2024 | 203.27B |
March 07, 2024 | 200.36B |
March 06, 2024 | 199.82B |
March 05, 2024 | 195.33B |
March 04, 2024 | 200.98B |
March 01, 2024 | 201.53B |
February 29, 2024 | 196.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
95.43B
Minimum
May 31 2019
241.85B
Maximum
May 10 2024
169.45B
Average
177.20B
Median
Market Cap Benchmarks
GSK PLC | 91.90B |
Adaptimmune Therapeutics PLC | 276.44M |
Biodexa Pharmaceuticals Plc | 4.078M |
Verona Pharma PLC | 1.198B |
Market Cap Related Metrics
PE Ratio | 38.33 |
PS Ratio | 5.118 |
PEG Ratio | 1.102 |
Price to Book Value | 6.459 |
Price to Free Cash Flow | 42.12 |
Price | 156.01 |
Earnings Yield | 2.61% |
PEGY Ratio | 1.046 |
Operating PE Ratio | 25.57 |
Normalized PE Ratio | 35.08 |